Medical Data Vision Co., Ltd.
Tokyo Stock ExchangeTotal Valuation
Medical Data Vision Co., Ltd. carries a market capitalization of 63.75B, placing it among publicly traded companies globally. Its enterprise value stands at 20.55B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 63.75B |
| Enterprise Value | 20.55B |
Share Statistics
Medical Data Vision Co., Ltd. currently has 38.20M shares outstanding.
| Shares Outstanding | 38.20M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Medical Data Vision Co., Ltd. trades at a trailing price-to-earnings ratio of 51.15. The price-to-sales ratio is 3.69, and the price-to-book ratio stands at 5.14.
| PE Ratio | 51.15 |
| PS Ratio | 3.69 |
| PB Ratio | 5.14 |
| P/TBV Ratio | 5.87 |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
The EV/Sales ratio of 3.32 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 19.06 provides insight into valuation relative to core operating earnings.
| EV / Sales | 3.32 |
| EV / EBITDA | 19.06 |
| EV / EBIT | 19.06 |
| EV / FCF | N/A |
Financial Position
Medical Data Vision Co., Ltd. maintains a current ratio of 2.41, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 2.41 |
| Quick Ratio | 1.58 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | N/A |
Financial Efficiency
Medical Data Vision Co., Ltd. posts a return on equity of 10.27 and a return on invested capital of 13.20.
| Return on Equity (ROE) | 10.27 |
| Return on Assets (ROA) | 8.00 |
| Return on Invested Capital (ROIC) | 13.20 |
| Return on Capital Employed (ROCE) | 10.73 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 302.52 |
Taxes
Over the trailing twelve months, Medical Data Vision Co., Ltd. has paid 417.67M in income taxes, reflecting an effective tax rate of 49.91.
| Income Tax | 417.67M |
| Effective Tax Rate | 49.91 |
Stock Price Statistics
Medical Data Vision Co., Ltd.'s stock has gained approximately 338.54167% over the past 52 weeks. The 50-day moving average sits at 1,682.26, while the 200-day moving average is 1,051.26.
| Beta (5Y) | N/A |
| 52-Week Price Change | 338.54167% |
| 50-Day Moving Average | 1,682.26 |
| 200-Day Moving Average | 1,051.26 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Medical Data Vision Co., Ltd. generated 6.20B in revenue and converted that into 447.32M in net income, yielding earnings per share of 10.97. EBITDA reached 1.08B, while operating income came in at 1.08B.
| Revenue | 6.20B |
| Gross Profit | 4.75B |
| Operating Income | 1.08B |
| Pretax Income | 836.82M |
| Net Income | 447.32M |
| EBITDA | 1.08B |
| EBIT | 1.08B |
| Earnings Per Share (EPS) | 10.97 |
Balance Sheet
Total book value stands at 4.45B, with working capital of 2.14B providing operational flexibility.
| Cash & Cash Equivalents | 2.39B |
| Total Debt | N/A |
| Net Debt | -2.39B |
| Equity (Book Value) | 4.45B |
| Book Value Per Share | 116.59 |
| Working Capital | 2.14B |
Margins
Medical Data Vision Co., Ltd. operates with a gross margin of 76.60, reflecting its pricing power and cost economics. The operating margin of 17.40 and net profit margin of 7.22 provide insight into operational efficiency.
| Gross Margin | 76.60 |
| Operating Margin | 17.40 |
| Pretax Margin | 13.50 |
| Profit Margin | 7.22 |
| EBITDA Margin | 17.40 |
Stock Splits
Medical Data Vision Co., Ltd.'s most recent stock split took place on April 25, 2018 with a 1:2 split ratio.
| Last Split Date | 4/25/2018 |
| Split Ratio | 1:2 |
Scores
Medical Data Vision Co., Ltd. posts an Altman Z-Score of 11.55, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 11.55 |